The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab

BACKGROUND: Patients with inflammatory bowel disease (IBD) have an elevated risk for infection which is further increased by immunosuppressive medications. The aim of this study was to evaluate the safety and immunogenicity of influenza, PVC13, PPSV23, and hepatitis B vaccines in adults with IBD tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrington, Jill E, Hamilton, Rachel E, Ganley-Leal, Lisa, Farraye, Francis A, Wasan, Sharmeel K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802260/
https://www.ncbi.nlm.nih.gov/pubmed/36777751
http://dx.doi.org/10.1093/crocol/otaa082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802260/
https://www.ncbi.nlm.nih.gov/pubmed/36777751
http://dx.doi.org/10.1093/crocol/otaa082

Ejemplares similares